565372-2026 - Planung
Finnland – Medizinische Ausrüstungen, Arzneimittel und Körperpflegeprodukte – REQUEST FOR INFORMATION: HUS 364-2026 Osseointegrated implant systems
OJ S 156/2026 14/08/2026
Vorinformation oder eine regelmäßige nicht verbindliche Bekanntmachung nur zu Informationszwecken
Lieferleistungen
1. Beschaffer
1.1.
Beschaffer
Offizielle Bezeichnung: HUS Group
E-Mail: kilpailutus.kirurgia@hus.fi
Rechtsform des Erwerbers: Regionale Gebietskörperschaft
Tätigkeit des öffentlichen Auftraggebers: Gesundheit
2. Verfahren
2.1.
Verfahren
Titel: REQUEST FOR INFORMATION: HUS 364-2026 Osseointegrated implant systems
Beschreibung: Helsinki University Hospital (HUS) and HUS Procurement is currently exploring solutions related to osseointegrated implant systems for patients with upper and/or lower limb loss. The purpose of this Request for Information (RFI) is to obtain information on products currently available on the market, their technical and clinical characteristics, implementation requirements, and supplier capabilities. The information obtained through this RFI will be used to increase HUS's understanding of the market and to support the planning of a potential future procurement process. SUBJECT OF THE MARKET DIALOGIA AND THE SOLUTION MAY INCLUDE: Intramedullary osseointegrated implants. Implant fixation components and connecting elements. Transcutaneous or equivalent prosthetic attachment systems. Surgical instruments and implantation equipment. Accessories and supporting products required for clinical use. Digital solutions, monitoring tools, or software related to the implant system, where applicable. Training, clinical support, and implementation services. The implant system should be intended to provide direct skeletal attachment of an external prosthesis as an alternative to conventional socket-based prosthetic solutions. SUPPLIERS ARE INVITATED TO PROVIDE INFORMATION ON THE FOLLOWING TOPICS: Company Information; name and contact details. Experience with osseointegrated implant systems. Product Information; name and commercial designation. Intended use and clinical indications. Description of the implant system and its main components. Available implant sizes, versions, and configurations. Materials used in the implant and connection components. Compatibility with external prosthetic systems. Clinical Evidence, available clinical studies and scientific publications, survival rates, complication rates, and long-term outcomes. References from hospitals currently using the system. Regulatory Information with certifications; CE marking status, Compliance with applicable European Union regulations. Surgical training requirements. Training programs for surgeons and clinical staff. Technical support and customer service. Guidance for patient follow-up and rehabilitation. Logistics and Commercial Information Product availability within Europe. Typical lead times. Product lifecycle expectations. Availability of spare parts and accessories. Information on maintenance, upgrades, and product development plans. MARKET DIALOGUE MEETING HUS procurement may invite selected suppliers to participate in a market dialogue meeting. The purpose of the discussions is to obtain further information regarding available solutions and market capabilities. Meetings may be arranged remotely via Microsoft Teams. DISCLAIMER This Request for Information is a preliminary market consultation and information-gathering exercise only. Participation in this RFI or any subsequent market dialogue does not create any obligation for HUS to initiate a procurement procedure, award a contract, or compensate suppliers for any costs incurred in preparing responses or participating in discussions. Neither the request for information nor its replies are binding on either party. Responding to a request for information does not affect the position of the tenderer in the forthcoming tender. The information provided by suppliers may be used solely for planning and preparing a potential future procurement process in accordance with applicable procurement legislation. SUBMISSION INSTRUCTIONS Suppliers are requested to submit their responses electronically in English. Responses should include all relevant supporting documentation, including product brochures, technical specifications, clinical evidence, and regulatory documentation where available. Answers should be submitted by 31.08.2026 12:00 GMT+2 at the latest to the email address: kilpailutus.kirurgia@hus.fi. The title or message field of the e-mail should mention: HUS 364-2026 Ortopediset Osseointegroitavat yläraajaimplantit.
Interne Kennung: 623738
2.1.1.
Zweck
Art des Auftrags: Lieferleistungen
Haupteinstufung (cpv): 33000000 Medizinische Ausrüstungen, Arzneimittel und Körperpflegeprodukte
2.1.2.
Erfüllungsort
Ort im Europäischen Wirtschaftsraum
2.1.4.
Allgemeine Informationen
Rechtsgrundlage: 
Richtlinie 2014/24/EU
3. Teil
3.1.
Teil: PAR-0000
Titel: REQUEST FOR INFORMATION: HUS 364-2026 Osseointegrated implant systems
Beschreibung: Helsinki University Hospital (HUS) and HUS Procurement is currently exploring solutions related to osseointegrated implant systems for patients with upper and/or lower limb loss. The purpose of this Request for Information (RFI) is to obtain information on products currently available on the market, their technical and clinical characteristics, implementation requirements, and supplier capabilities. The information obtained through this RFI will be used to increase HUS's understanding of the market and to support the planning of a potential future procurement process. SUBJECT OF THE MARKET DIALOGIA AND THE SOLUTION MAY INCLUDE: Intramedullary osseointegrated implants. Implant fixation components and connecting elements. Transcutaneous or equivalent prosthetic attachment systems. Surgical instruments and implantation equipment. Accessories and supporting products required for clinical use. Digital solutions, monitoring tools, or software related to the implant system, where applicable. Training, clinical support, and implementation services. The implant system should be intended to provide direct skeletal attachment of an external prosthesis as an alternative to conventional socket-based prosthetic solutions. SUPPLIERS ARE INVITATED TO PROVIDE INFORMATION ON THE FOLLOWING TOPICS: Company Information; name and contact details. Experience with osseointegrated implant systems. Product Information; name and commercial designation. Intended use and clinical indications. Description of the implant system and its main components. Available implant sizes, versions, and configurations. Materials used in the implant and connection components. Compatibility with external prosthetic systems. Clinical Evidence, available clinical studies and scientific publications, survival rates, complication rates, and long-term outcomes. References from hospitals currently using the system. Regulatory Information with certifications; CE marking status, Compliance with applicable European Union regulations. Surgical training requirements. Training programs for surgeons and clinical staff. Technical support and customer service. Guidance for patient follow-up and rehabilitation. Logistics and Commercial Information Product availability within Europe. Typical lead times. Product lifecycle expectations. Availability of spare parts and accessories. Information on maintenance, upgrades, and product development plans. MARKET DIALOGUE MEETING HUS procurement may invite selected suppliers to participate in a market dialogue meeting. The purpose of the discussions is to obtain further information regarding available solutions and market capabilities. Meetings may be arranged remotely via Microsoft Teams. DISCLAIMER This Request for Information is a preliminary market consultation and information-gathering exercise only. Participation in this RFI or any subsequent market dialogue does not create any obligation for HUS to initiate a procurement procedure, award a contract, or compensate suppliers for any costs incurred in preparing responses or participating in discussions. Neither the request for information nor its replies are binding on either party. Responding to a request for information does not affect the position of the tenderer in the forthcoming tender. The information provided by suppliers may be used solely for planning and preparing a potential future procurement process in accordance with applicable procurement legislation. SUBMISSION INSTRUCTIONS Suppliers are requested to submit their responses electronically in English. Responses should include all relevant supporting documentation, including product brochures, technical specifications, clinical evidence, and regulatory documentation where available. Answers should be submitted by 31.08.2026 12:00 GMT+2 at the latest to the email address: kilpailutus.kirurgia@hus.fi. The title or message field of the e-mail should mention: HUS 364-2026 Ortopediset Osseointegroitavat yläraajaimplantit.
Interne Kennung: 623738
3.1.1.
Zweck
Art des Auftrags: Lieferleistungen
Haupteinstufung (cpv): 33000000 Medizinische Ausrüstungen, Arzneimittel und Körperpflegeprodukte
3.1.2.
Erfüllungsort
Ort im Europäischen Wirtschaftsraum
3.1.5.
Allgemeine Informationen
Vorbehaltene Teilnahme: 
Teilnahme ist nicht vorbehalten.
Die Beschaffung fällt unter das Übereinkommen über das öffentliche Beschaffungswesen: ja
3.1.6.
Auftragsunterlagen
Sprachen, in denen die Auftragsunterlagen offiziell verfügbar sind: Englisch
Internetadresse der Auftragsunterlagen: https://tarjouspalvelu.fi/huslogistiikka?id=623738&tpk=baa4d325-0199-4e29-b33f-6a7f224b96ac
3.1.7.
Bedingungen für die Auftragsvergabe
Die Auftragsausführung muss im Rahmen von Programmen für geschützte Beschäftigungsverhältnisse erfolgen: Nein
3.1.9.
Weitere Informationen, Schlichtung und Nachprüfung
Überprüfungsstelle: Markkinaoikeus
8. Organisationen
8.1.
ORG-0001
Offizielle Bezeichnung: Markkinaoikeus
Registrierungsnummer: 3006157-6
Postanschrift: Radanrakentajantie 5
Stadt: Helsinki
Postleitzahl: 00520
Land, Gliederung (NUTS): Helsinki-Uusimaa (FI1B1)
Land: Finnland
E-Mail: markkinaoikeus@oikeus.fi
Telefon: +358 295643300
Internetadresse: http://www.oikeus.fi/markkinaoikeus
Rollen dieser Organisation: 
Überprüfungsstelle
8.1.
ORG-0002
Offizielle Bezeichnung: HUS Group
Registrierungsnummer: 1567535-0
Postanschrift: Uutistie 5 (PO Box 441, 00029 HUS)
Stadt: Vantaa
Postleitzahl: 01770
Land, Gliederung (NUTS): Helsinki-Uusimaa (FI1B1)
Land: Finnland
Kontaktperson: Kirurgia, sisätaudit ja kardiologia
E-Mail: kilpailutus.kirurgia@hus.fi
Telefon: +358 94711
Internetadresse: http://www.hus.fi
Rollen dieser Organisation: 
Beschaffer
8.1.
ORG-0003
Offizielle Bezeichnung: Hansel Oy (Hilma)
Registrierungsnummer: FI09880841
Postanschrift: Mannerheiminaukio 1a
Stadt: Helsinki
Postleitzahl: 00100
Land, Gliederung (NUTS): Helsinki-Uusimaa (FI1B1)
Land: Finnland
Kontaktperson: eSender
E-Mail: tekninen@hankintailmoitukset.fi
Telefon: 029 55 636 30
Internetadresse: http://hankintailmoitukset.fi
Rollen dieser Organisation: 
TED eSender
Informationen zur Bekanntmachung
Kennung/Fassung der Bekanntmachung: 2e1a67f7-0874-4453-bfc1-9d42ed246aad  -  01
Formulartyp: Planung
Art der Bekanntmachung: Vorinformation oder eine regelmäßige nicht verbindliche Bekanntmachung nur zu Informationszwecken
Unterart der Bekanntmachung: 4
Datum der Übermittlung der Bekanntmachung: 13/08/2026 10:43:23 (UTC+00:00) Westeuropäische Zeit, GMT
Bekanntmachung — eSender-Übermittlungsdatum: 13/08/2026 10:43:25 (UTC+00:00) Westeuropäische Zeit, GMT
Sprachen, in denen diese Bekanntmachung offiziell verfügbar ist: Englisch
Veröffentlichungsnummer der Bekanntmachung: 565372-2026
ABl. S – Nummer der Ausgabe: 156/2026
Datum der Veröffentlichung: 14/08/2026
Voraussichtliches Datum der Veröffentlichung einer Auftragsbekanntmachung im Rahmen dieses Verfahrens: 15/02/2027